Literature DB >> 8161498

Membrane interaction and conformational properties of the putative fusion peptide of PH-30, a protein active in sperm-egg fusion.

A Muga1, W Neugebauer, T Hirama, W K Surewicz.   

Abstract

A peptide representing the putative fusion domain of PH-30, a sperm surface protein involved in sperm-egg fusion, was synthesized, and its interaction with model lipid membranes was characterized by biophysical methods. While the peptide binds to the vesicles composed of both neutral and acidic lipids, the apparent affinity is significantly higher for the latter lipid class. The intervesicular lipid mixing assay suggests that the synthetic peptide is able to induce fusion of large unilamellar vesicles. Circular dichroism and Fourier-transform infrared spectroscopy show that while in an aqueous buffer the peptide exists in an essentially unordered conformation, binding to the membranes results in a conformational transition to a beta-structure. These data indicate that the fragment identified on the alpha-subunit of PH-30 as a putative fusion peptide is indeed a good candidate for this role. However, in contrast to what has been proposed for some viral fusion peptides, the PH-30 fusion domain is highly unlikely to act as an insertional "sided" helix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161498     DOI: 10.1021/bi00181a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer.

Authors:  A S Ulrich; W Tichelaar; G Förster; O Zschörnig; S Weinkauf; H W Meyer
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

2.  A soluble peripherin/Rds C-terminal polypeptide promotes membrane fusion and changes conformation upon membrane association.

Authors:  Kathleen Boesze-Battaglia; Andrew F X Goldberg; Janice Dispoto; Madan Katragadda; Gregory Cesarone; Arlene D Albert
Journal:  Exp Eye Res       Date:  2003-10       Impact factor: 3.467

3.  Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment.

Authors:  S C Li; N K Goto; K A Williams; C M Deber
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Secondary structure and distribution of fusogenic LV-peptides in lipid membranes.

Authors:  J Ollesch; B C Poschner; J Nikolaus; M W Hofmann; A Herrmann; K Gerwert; D Langosch
Journal:  Eur Biophys J       Date:  2007-11-24       Impact factor: 1.733

5.  Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers.

Authors:  C Gray; S A Tatulian; S A Wharton; L K Tamm
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

6.  Protein involvement in the fusion between the equatorial segment of acrosome-reacted human spermatozoa and liposomes.

Authors:  E G Arts; J G Wijchman; S Jager; D Hoekstra
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

7.  The central proline of an internal viral fusion peptide serves two important roles.

Authors:  S E Delos; J M Gilbert; J M White
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells.

Authors:  B S Coulson; S L Londrigan; D J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

9.  The transmembrane homotrimer of ADAM 1 in model lipid bilayers.

Authors:  Siok Wan Gan; Lin Xin; Jaume Torres
Journal:  Protein Sci       Date:  2006-12-22       Impact factor: 6.725

10.  Effect of nanomolar concentrations of sodium dodecyl sulfate, a catalytic inductor of alpha-helices, on human calcitonin incorporation and channel formation in planar lipid membranes.

Authors:  Silvia Micelli; Daniela Meleleo; Vittorio Picciarelli; Maria G Stoico; Enrico Gallucci
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.